Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

ClinicalTrials.gov ID: NCT05514548

Public ClinicalTrials.gov record NCT05514548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of Two Doses of INV-202 in Patients With Diabetic Kidney Disease

Study identification

NCT ID
NCT05514548
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Inversago Pharma Inc.
Industry
Enrollment
265 participants

Conditions and interventions

Interventions

  • INV-202 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 18, 2022
Primary completion
Aug 19, 2024
Completion
Sep 2, 2024
Last update posted
Aug 10, 2025

2022 – 2024

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
National Institute of Clinical Research, Inc. Garden Grove California 92844
National Institute of Clinical Research, Inc - Pomona Pomona California 91768
Central Coast Nephrology Salinas California 93901
North American Research Institute San Dimas California 91773
National Institute of Clinical Research, Inc - Upland Upland California 91786
Research Physicians Network Alliance Boca Raton Florida 33431
ALL Medical Research, LLC Cooper City Florida 33024
South Florida Research Institute Lauderdale Lakes Florida 33313
Endocrine Research Solutions, Inc. Roswell Georgia 30076
Research by Design, LLC Chicago Illinois 60643
Endocrine and metabolic Consultants Rockville Maryland 20852
Clinical Research Consultants, LLC Kansas City Missouri 64111
Palm Research Center, Inc Las Vegas Nevada 89148
Physicians East, PA Greenville North Carolina 27834
Northeast Clinical Research Center Bethlehem Pennsylvania 18017
South Carolina Clinical Research LLC Orangeburg South Carolina 29118
Knoxville Kidney Center, Pllc Knoxville Tennessee 37923
North Texas Endocrine Center Dallas Texas 75231
Biopharma Informatic, LLC Houston Texas 77084
Linq Research, LLC Pearland Texas 77584
Linq Research, LLC Pearland Texas 77854
Clinical Advancement Center, PLLC San Antonio Texas 78212
University of Vermont Medical Center Burlington Vermont 05401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05514548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05514548 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →